Treatment of Hemorrhagic Ovarian Cysts

Management Based on Size and Patient Characteristics

The American College of Radiology recommends that typical hemorrhagic cysts ≤5 cm in premenopausal women require no further management 1, 2, 3, 4
For typical hemorrhagic cysts >5 cm but <10 cm in premenopausal women, follow-up ultrasound in 8-12 weeks is recommended 1, 2, 3
If the cyst persists or enlarges during follow-up, referral to an ultrasound specialist, gynecologist, or MRI is recommended 1, 3
Hemorrhagic cysts with changing morphology or developing vascular components in premenopausal women should be referred for specialist evaluation 1, 4
In postmenopausal women, hemorrhagic cysts should not typically occur, but when found (<10 cm), further evaluation by ultrasound specialist, gynecologist, or MRI is required 1, 2, 3

Ultrasound is the first-line diagnostic tool for hemorrhagic ovarian cysts, according to the American College of Radiology 5, 6
Characteristic findings on ultrasound include a reticular pattern (fine thin intersecting lines representing fibrin strands) 1, 4, 7
A retracting clot (avascular echogenic component with angular, straight, or concave margins) is also a characteristic finding 1, 4, 7
Peripheral vascularity with absence of internal blood flow is another characteristic finding 4, 6

For patients on anticoagulation therapy with cyst hemorrhage, interrupting aspirin for 3 days following hemorrhage onset is recommended 8, 9
Consider restarting anticoagulants between 7-15 days after hemorrhage onset 8, 9
For patients on dual antiplatelet therapy, continue P2Y12 inhibitor while interrupting aspirin 8, 9

Fine-needle aspiration of ovarian cysts is contraindicated, as recommended by the British Journal of Cancer 10

For resolving cysts, no further follow-up is needed, according to the American College of Radiology 1, 2, 3
For persistent cysts, consider gynecologic referral for further management 1, 3
The risk of malignancy in sonographically benign-appearing lesions is extremely low (<1%), as reported by the Journal of the American College of Radiology 6

Invasive procedures should not be performed during active hemorrhage, as recommended by the Journal of Hepatology 8, 9
Misdiagnosing pedunculated fibroids as ovarian masses should be avoided, according to the American College of Radiology 5, 6
Assuming all adnexal masses in premenopausal women are functional should be avoided, and appropriate guidelines for persistent masses should be followed 6

For a premenopausal woman with a hemorrhagic ovarian cyst, the American College of Radiology recommends follow-up ultrasound in 8-12 weeks, and if the cyst persists or enlarges, refer to a gynecologist or obtain MRI for further characterization, with a strength of evidence based on expert consensus 11
The O-RADS risk classification system categorizes hemorrhagic cysts as O-RADS 2 (almost certainly benign, <1% malignancy risk) if they demonstrate classic hemorrhagic features, according to the Radiology journal 12

If surgical intervention becomes necessary, a general gynecologist can manage O-RADS 2-3 lesions, while O-RADS 4 lesions warrant consultation with gynecologic oncology prior to removal, and O-RADS 5 lesions should be directly referred to gynecologic oncology, as recommended by the Radiology journal 12
The use of color Doppler to evaluate for internal vascularity is crucial in differentiating between solid and hemorrhagic components, as suggested by the Journal of the American College of Radiology 11